Effects of chorioamnionitis and prenatal glucocorticoid on fetal lung maturation and development in preterm rats
返回论文页
|更新时间:2023-12-18
|
Effects of chorioamnionitis and prenatal glucocorticoid on fetal lung maturation and development in preterm rats
Journal of Chongqing Medical UniversityVol. 36, Issue 10, Pages: 1138-1143(2013)
作者机构:
重庆医科大学附属第一医院妇产科,重庆,400016
作者简介:
基金信息:
DOI:
CLC:
Published:2013,
扫 描 看 全 文
LI Juan, LUO Xin, YANG Zhongmei, et al. Effects of chorioamnionitis and prenatal glucocorticoid on fetal lung maturation and development in preterm rats. [J]. Journal of Chongqing Medical University 36(10):1138-1143(2013)
DOI:
LI Juan, LUO Xin, YANG Zhongmei, et al. Effects of chorioamnionitis and prenatal glucocorticoid on fetal lung maturation and development in preterm rats. [J]. Journal of Chongqing Medical University 36(10):1138-1143(2013)DOI:
Effects of chorioamnionitis and prenatal glucocorticoid on fetal lung maturation and development in preterm rats
Objective:To determine the effects of different degrees of chorioamnionitis(CA) and prenatal glucocorticoid on fetal lung maturation and development in preterm rats. Methods:Totally 36 pregnant SD rats were randomly assigned to 6 groups. A group:normal saline(NS)+dexamethasone(DEX);B group:lipopolysaccharide(LPS) 0.5 μg DEX;C group:LPS 4.0 μg DEX;D group:NS NS;E group:LPS 0.5 μg NS;F group:LPS 4.0 μg NS. All groups underwent intraamniotic injection with NS,LPS(0.5 μg and 4.0 μg respectively) on gestational day 19;24 h later,rats were intramuscularly injected with DEX 0.4 mg and NS respectively. After another 24 h,pathological inflammation of placenta,chorioamnion and fetal lung were observed. Surfactant protein A,B,C(SP-A,SP-B,SP-C) and interleukin-1β(IL-1β),tumor necrosis factor-α(TNF-α) mRNAs in lung were determined by quantitative real-time PCR(qRT-PCR). Lung morphologic observation was performed on postnatal day 15(P15). Results:①fetal rat mortality in C,F groups were higher than that in other groups;rat survival rate in C,F groups were lower than that in other groups(P all <0.05). ②Pathologi-cal grading of pulmonary inflammation and CA:C and F groups were the highest,followed by B and E groups and A and D groups were the lowest(P all <0.05). ③Relative expression of SP-A,SP-C mRNAs:D and F groups were lower than other groups,B group was the highest(P all <0.05);relative expression of SP-B mRNA:D,E,F groups were lower than other groups,B and C groups were the highest(P all <0.05). ④Relative expression of IL-1β mRNA:F group was the highest(P<0.05). Relative expression of TNF-α mRNA:C and F groups were the highest while A and D groups were the lowest(P<0.05). ⑤On P15,C group alveolarization was significantly inhibited. Conclusions:Different doses of intraam-niotic LPS could induce CA and fetal lung inflammation with different degrees. Histological inflammation aggravates with LPS dose increasing. Mild to moderate CA and antenatal DEX will not adversely affect the survival rate nor inhibit fetus and newborn growth. Inflammation was not suppressed but synergistically induced more significant lung maturation. Severe CA and prenatal DEX might cause adverse effects,particularly,increasing the risk of bronchopulmonary dysplasia.
Effect of lipopolysaccharide via intranasal instillation on lung development in neonatal mice and its mechanism
Cloning and expression analysis of surfactant-associated protein D in cotton rat with lung injury induced by lipopolysaccharide
LPS induced HIF-1α expression of RAW264.7 cells under hypoxia by simultaneously activating p38/MAPK and NF-κB signal pathway
Risk factors for bronchopulmonary dysplasia in neonates with respiratory distress syndrome
Related Author
Feng Yi
Ren Luo
Huang Daochao
Li Yasha
Zhong Haiying
Zhao Li
Fu Zhihui
Xu Ling
Related Institution
Department of Pediatric Research Institute,the Children’s Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders,Chongqing Key Laboratory of Pediatrics,Chongqing International Science and Technology Cooperation Center for Child Development and Disorders
Chongqing Key Laboratory for Oral Diseases and Biomedical Sciences
Department of Neonatology,the Children’s Hospital,Chongqing Medical University,Ministry of Key Laboratory of Child Development and Disorders,China international Science and Technology Cooperation base of Child development and Critical Disorders,Chongqing Laboratory of Pediatrics
Department of Neurology,the Children’s Hospital,Chongqing Medical University
Department of Dermatology,The First Affiliated Hospital of Chongqing Medical University